HELSINN HEALTHCARE S.A., PETITIONER,
v.
TEVA PHARMACEUTICALS USA, INC., ET AL.
HELSINN HEALTHCARE S.A., PETITIONER,
TEVA PHARMACEUTICALS USA, INC., ET AL.
138 S. Ct. 2678
Supreme Court of the United States (2018)
Positive Treatment
Cited by 4 cases
Opinion
Full opinion text not available for this case.
Cases With Similar Vibessemantic neighbors from the corpus
Citator
Cited By
-
Henry Schein, Inc. v. Archer & White Sales, Inc., 139 S. Ct. 524 (U.S. 2019)…hein's motion to compel arbitration. The Fifth Circuit affirmed. In light of disagreement in the Courts of Appeals over whether the "wholly groundless" exception is consistent with the Federal Arbitration Act, we granted certiorari, 585 U.S. ----, 138 S.Ct. 2678, 201 L.Ed.2d 1071 (2018). Compare 878 F. 3d 488 (C.A.5 2017) (case below); Simply Wireless, Inc. v. T-Mobile US, Inc., 877 F. 3d 522 (C.A.4 2017) ; Douglas v. Regions Bank, 757 F. 3d 460 (C.A.5 2014) ; Turi v. Main Street Adoption Servs., LLP, 633…
-
Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc., 139 S. Ct. 628 (U.S. 2019)…iorari to determine whether, under the AIA, an inventor's sale of an invention to a third party who is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. 585 U.S. ----, 138 S.Ct. 2678, 201 L.Ed.2d 1070 (2018). We conclude that such a sale can qualify as prior art. II A The United States Constitution authorizes Congress "[t]o promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors…